NOS2 and glaucoma: Triamcinolone acetonide and amcinonide (corticosteroids), thought to be inhibitors of microglial activation, may provide candidature for glaucoma therapy.30 These agents also inhibit TNFα and iNOS production thereby lending support to the findings of the present mathematical model.